Medical Billing Code Search
What is a code?
7752 results found
C1204 | Tc 99m tilmanocept | Description: Technetium tc 99m tilmanocept, diagnostic, up to 0.5 millicuries |
C1879 | Tissue marker, implantable | Description: Tissue marker (implantable) |
C9130 | Injection, ivig bivigam | Description: Injection, immune globulin (bivigam), 500 mg |
C9131 | In ado-trastuzumab emtansine | Description: Injection, ado-trastuzumab emtansine, 1 mg |
C9292 | Injection, pertuzumab | Description: Injection, pertuzumab, 10 mg |
C9294 | Inj, taliglucerase alfa | Description: Injection, taliglucerase alfa, 10 units |
C9295 | Injection, carfilzomib | Description: Injection, carfilzomib, 1 mg |
C9296 | Injection, ziv-aflibercept | Description: Injection, ziv-aflibercept, 1 mg |
C9297 | Omacetaxine mepesuccinate | Description: Injection, omacetaxine mepesuccinate, 0.01 mg |
C9298 | Injection, ocriplasmin | Description: Injection, ocriplasmin, 0.125 mg |
C9736 | Lap ablate uteri fibroid rf | Description: Laparoscopy, surgical, radiofrequency ablations of uterine fibroid(s), including intraoperative guidance and monitoring, when performed |
G0275 | Renal angio, cardiac cath | Description: Renal angiography, non-selective, one or both kidneys, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of any catheter in the abdominal aorta at or near the origins (ostia) of the renal arteries, injection of dye, flush aortogram, production of permanent images, and radiologic supervision and interpretation (list separately in addition to primary procedure) |
G8459 | Doc pt rec antivir treat | Description: Clinician documented that patient is receiving antiviral treatment for hepatitis c |
G8462 | Pt inelig couns no antvir tx | Description: Clinician documented that patient is not an eligible candidate for counseling regarding contraception prior to antiviral treatment; patient not receiving antiviral treatment for hepatitis c |
G8463 | Pt rec antiviral treat doc | Description: Patient receiving antiviral treatment for hepatitis c documented |
G8556 | Ref to doc otolog eval | Description: Referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation |
G8557 | Pt inelig ref otolog eval | Description: Patient is not eligible for the referral for otologic evaluation measure |
G8558 | No ref to doc otolog eval | Description: Not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given |
G8588 | Sys bp <140 | Description: Most recent systolic blood pressure < 140 mmhg |
G8589 | Sys bp >= 140 | Description: Most recent systolic blood pressure >= 140 mmhg |
G8590 | Dia bp < 90 | Description: Most recent diastolic blood pressure < 90 mmhg |
G8591 | Dia bp >= 90 | Description: Most recent diastolic blood pressure >= 90 mmhg |
G8592 | No bp measure | Description: No documentation of blood pressure measurement, reason not given |
G8596 | No ldl perf | Description: Ldl-c was not performed |
G8603 | Spok lang comp score | Description: Score on the spoken language comprehension functional communication measure at discharge was higher than at admission |
G8604 | No high score spok lang | Description: Score on the spoken language comprehension functional communication measure at discharge was not higher than at admission, reason not given |
G8605 | No spok lang comp score | Description: Patient treated for spoken language comprehension but not scored on the spoken language comprehension functional communication measure either at admission or at discharge |
G8606 | Attention score | Description: Score on the attention functional communication measure at discharge was higher than at admission |
G8607 | No high score attention | Description: Score on the attention functional communication measure at discharge was not higher than at admission, reason not given |
G8608 | No attention score | Description: Patient treated for attention but not scored on the attention functional communication measure either at admission or at discharge |
G8609 | Memory score | Description: Score on the memory functional communication measure at discharge was higher than at admission |
G8610 | No high score memory | Description: Score on the memory functional communication measure at discharge was not higher than at admission, reason not given |
G8611 | No memory score | Description: Patient treated for memory but not scored on the memory functional communication measure either at admission or at discharge |
G8612 | Moto speech score | Description: Score on the motor speech functional communication measure at discharge was higher than at admission |
G8613 | No high score moto speech | Description: Score on the motor speech functional communication measure at discharge was not higher than at admission, reason not given |
G8614 | No moto speech score | Description: Patient treated for motor speech but not scored on the motor speech comprehension functional communication measure either at admission or at discharge |
G8615 | Reading score | Description: Score on the reading functional communication measure at discharge was higher than at admission |
G8616 | No high score reading | Description: Score on the reading functional communication measure at discharge was not higher than at admission, reason not given |
G8617 | No reading score | Description: Patient treated for reading but not scored on the reading functional communication measure either at admission or at discharge |
G8618 | Spok lang exp score | Description: Score on the spoken language expression functional communication measure at discharge was higher than at admission |
G8619 | No high score spok lang exp | Description: Score on the spoken language expression functional communication measure at discharge was not higher than at admission, reason not given |
G8620 | No spok lang exp score | Description: Patient treated for spoken language expression but not scored on the spoken language expression functional communication measure either at admission or at discharge |
G8621 | Writing score | Description: Score on the writing functional communication measure at discharge was higher than at admission |
G8622 | No high score writing | Description: Score on the writing functional communication measure at discharge was not higher than at admission, reason not given |
G8623 | No writing score | Description: Patient treated for writing but not scored on the writing functional communication measure either at admission or at discharge |
G8624 | Swallowing score | Description: Score on the swallowing functional communication measure at discharge was higher than at admission |
G8625 | No high score swallowing | Description: Score on the swallowing functional communication measure at discharge was not higher than at admission, reason not given |
G8626 | No swallowing score | Description: Patient treated for swallowing but not scored on the swallowing functional communication measure at admission or at discharge |
G8642 | Hrdshp rural w/o internet | Description: The eligible professional practices in a rural area without sufficient high speed internet access and requests a hardship exemption from the application of the payment adjustment under section 1848(a)(5)(a) of the social security act |
G8643 | Hrdshp w/o suff pharm w/erx | Description: The eligible professional practices in an area without sufficient available pharmacies for electronic prescribing and requests a hardship exemption for the application of the payment adjustment under section 1848(a)(5)(a) of the social security act |
G8644 | Ep no prescribe priv | Description: Eligible professional does not have prescribing privileges |
G8741 | Not tx spoken lang | Description: Patient not treated for spoken language comprehension disorder |
G8742 | Not tx attention | Description: Patient not treated for attention disorder |
G8743 | Not tx memory | Description: Patient not treated for memory disorder |
G8744 | Not tx motor speech | Description: Patient not treated for motor speech disorder |
G8745 | Not tx reading | Description: Patient not treated for reading disorder |
G8746 | Not tx spoken lang express | Description: Patient not treated for spoken language expression disorder |
G8747 | Not tx writing | Description: Patient not treated for writing disorder |
G8748 | Not tx swallowing | Description: Patient not treated for swallowing disorder |
G8790 | Systolic <130mmhg | Description: Most recent office visit systolic blood pressure <130 mm hg |
G8791 | Systolic 130-139mmhg | Description: Most recent office visit systolic blood pressure, 130 to 139 mm hg |
G8792 | Systolic >=140mmhg | Description: Most recent office visit systolic blood pressure >=140 mm hg |
G8793 | Diastolic <80mmhg | Description: Most recent office visit diastolic blood pressure, <80 mm hg |
G8794 | Diastolic 80-89mmhg | Description: Most recent office visit diastolic blood pressure, 80 - 89 mm hg |
G8795 | Diastolic >=90mmhg | Description: Most recent office visit diastolic blood pressure >=90 mm hg |
G8796 | Bp not doc | Description: Blood pressure measurement not documented, reason not given |
G8799 | Anticoag ordered | Description: Anticoagulation ordered |
G8800 | Doc reas anticoag not order | Description: Anticoagulation not ordered for reasons documented by clinician |
G8801 | Anticoag not ordered | Description: Anticoagulation was not ordered, reason not given |
G8812 | Pt not elig cta, duplex, mra | Description: Patient is not eligible for follow-up cta, duplex, or mra (e.g., patient death, failure to return for scheduled follow-up exam, planned follow-up study which will meet numerator criteria has not yet occurred at the time of reporting) |
G8813 | Cta, duplex, mra performed | Description: Follow-up cta, duplex, or mra of the abdomen and pelvis performed |
G8814 | No cta, duplex, mra | Description: Follow-up cta, duplex, or mra of the abdomen and pelvis not performed |
G8827 | Aneurysm <= 5.5cm for women | Description: Aneurysm minor diameter <= 5.5 cm for women |
G8835 | Asymptom no trans | Description: Asymptomatic patient with no history of any transient ischemic attack or stroke in any carotid or vertebrobasilar territory |
G8919 | Mst rcnt sys bp <140mmg | Description: Most recent systolic blood pressure < 140 mmhg |
G8920 | Mst rcnt sys bp >=140mmhg | Description: Most recent systolic blood pressure >= 140 mmhg |
G8921 | Mst rcnt dia bp <90mmhg | Description: Most recent diastolic blood pressure < 90 mmhg |
G8922 | Mst rcnt dia bp >=90mmhg | Description: Most recent diastolic blood pressure >= 90 mmhg |
G8945 | Aneurysm <=6 cm for men | Description: Aneurysm minor diameter <= 6 cm for men |
G8954 | Pt data rpt qual clin db reg | Description: Complete and appropriate patient data were reported to a qualified clinical database registry |
J0152 | Adenosine injection | Description: Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) |
J0718 | Certolizumab pegol inj | Description: Injection, certolizumab pegol, 1 mg |
J1441 | Filgrastim 480 mcg injection | Description: Injection, filgrastim (g-csf), 480 mcg |
J3487 | Zoledronic acid | Description: Injection, zoledronic acid (zometa), 1 mg |
J3488 | Reclast injection | Description: Injection, zoledronic acid (reclast), 1 mg |
J9002 | Doxil injection | Description: Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg |
L0430 | Dewall posture protector | Description: Spinal orthosis, anterior-posterior-lateral control, with interface material, custom fitted (dewall posture protector only) |
Q0090 | Skyla 13.5mg | Description: Levonorgestrel-releasing intrauterine contraceptive system, (skyla), 13.5 mg |
Q0165 | Prochlorperazine maleate10mg | Description: Prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0168 | Dronabinol 5mg oral | Description: Dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0170 | Promethazine hcl 25 mg oral | Description: Promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0171 | Chlorpromazine hcl 10mg oral | Description: Chlorpromazine hydrochloride, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0172 | Chlorpromazine hcl 25mg oral | Description: Chlorpromazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0176 | Perphenazine 8mg oral | Description: Perphenazine, 8mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0178 | Hydroxyzine pamoate 50mg | Description: Hydroxyzine pamoate, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0505 | Miscl supply/accessory vad | Description: Miscellaneous supply or accessory for use with ventricular assist device |
Q2027 | Sculptra injection | Description: Injection, sculptra, 0.1 ml |
Q2033 | Influenza vaccine, (flublok) | Description: Influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok) |
Q2051 | Zoldedronic acid 1mg | Description: Injection, zoledronic acid, not otherwise specified, 1mg |
Q3025 | Im inj interferon beta 1-a | Description: Injection, interferon beta-1a, 11 mcg for intramuscular use |
Q3026 | Subc inj interferon beta-1a | Description: Injection, interferon beta-1a, 11 mcg for subcutaneous use |
S3625 | Maternal triple screen test | Description: Maternal serum triple marker screen including alpha-fetoprotein (afp), estriol, and human chorionic gonadotropin (hcg) |
S3626 | Maternal serum quad screen | Description: Maternal serum quadruple marker screen including alpha-fetoprotein (afp), estriol, human chorionic gonadotropin (hcg) and inhibin a |
S3833 | Comp apc sequence | Description: Complete apc gene sequence analysis for susceptibility to familial adenomatous polyposis (fap) and attenuated fap |
S3834 | Sing mutation apc | Description: Single-mutation analysis (in individual with a known apc mutation in the family) for susceptibility to familial adenomatous polyposis (fap) and attenuated fap |
L3891 | Torsion mechanism wristelbo | Description: Addition to upper extremity joint wrist or elbow concentric adjustable torsion style mechanism for custom fabricated orthotics only each |
S1016 | Non-pvc intravenous administ | Description: Non-pvc (polyvinyl chloride) intravenous administration set for use with drugs that are not stable in pvc e.g. paclitaxel |
S1015 | Iv tubing extension set | Description: Iv tubing extension set |
S9451 | Exercise class | Description: Exercise classes non-physician provider per session |
V2308 | Lens sphc trifocal 4.25-72. | Description: Spherocylinder trifocal plus or minus 4.25 to plus or minus 7.00d sphere 2.12 to 4.00d cylinder per lens |
L3090 | Arch supp att to shoe longm | Description: Foot arch support non-removable attached to shoe longitudinalmetatarsal each |
V2309 | Lens sphc trifocal 4.25-74. | Description: Spherocylinder trifocal plus or minus 4.25 to plus or minus 7.00d sphere 4.25 to 6.00d cylinder per lens |
S2351 | Diskectomy anterior with d | Description: Diskectomy anterior with decompression of spinal cord andor nerve root(s) including osteophytectomy lumbar each additional interspace (list separately in addition to code for primary procedure) |
J8540 | Oral dexamethasone | Description: Dexamethasone oral 0.25 mg |
L6910 | Hand restoration no fingers | Description: Hand restoration (casts shading and measurements included) partial hand with glove no fingers remaining |
L6915 | Hand restoration replacmnt g | Description: Hand restoration (shading and measurements included) replacement glove for above |
S5000 | Prescription drug generic | Description: Prescription drug generic |
V2302 | Lens sphere trifocal 7.12-20 | Description: Sphere trifocal plus or minus 7.12 to plus or minus 20.00 per lens |
V2303 | Lens sphcy trifocal 4.0.12- | Description: Spherocylinder trifocal plano to plus or minus 4.00d sphere .12-2.00d cylinder per lens |
E1295 | Wheelchair heavy duty fixed | Description: Heavy duty wheelchair fixed full length arms elevating legrest |
E2606 | Position wc cush wdth>=22 in | Description: Positioning wheelchair seat cushion width 22 inches or greater any depth |
L8513 | Trach pros cleaning device | Description: Cleaning device used with tracheoesophageal voice prosthesis pipet brush or equal replacement only each |
L8512 | Gel cap for trach voice pros | Description: Gelatin capsules or equivalent for use with tracheoesophageal voice prosthesis replacement only per 10 |
L8511 | Indwelling trach insert | Description: Insert for indwelling tracheoesophageal prosthesis with or without valve replacement only each |
L8510 | Voice amplifier | Description: Voice amplifier |
E1290 | Wheelchair hvy duty detach a | Description: Heavy duty wheelchair detachable arms (desk or full length) swing away detachable footrest |
L8515 | Gel cap app device for trach | Description: Gelatin capsule application device for use with tracheoesophageal voice prosthesis each |
L8514 | Repl trach puncture dilator | Description: Tracheoesophageal puncture dilator replacement only each |
L0999 | Add to spinal orthosis nos | Description: Addition to spinal orthosis not otherwise specified |
G0381 | Lev 2 hosp type b ed visit | Description: Level 2 hospital emergency department visit provided in a type b emergency department (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or |
G0380 | Lev 1 hosp type b ed visit | Description: Level 1 hospital emergency department visit provided in a type b emergency department (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or |
G0383 | Lev 4 hosp type b ed visit | Description: Level 4 hospital emergency department visit provided in a type b emergency department (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or |
G0382 | Lev 3 hosp type b ed visit | Description: Level 3 hospital emergency department visit provided in a type b emergency department (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or |
G0384 | Lev 5 hosp type b ed visit | Description: Level 5 hospital emergency department visit provided in a type b emergency department (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or |
G0389 | Ultrasound exam aaa screen | Description: Ultrasound b-scan andor real time with image documentation for abdominal aortic aneurysm (aaa) screening |
A4389 | Drainable pch w st wear barr | Description: Ostomy pouch drainable with barrier attached with built-in convexity (1 piece) each |
A4388 | Drainable pch w ex wear barr | Description: Ostomy pouch drainable with extended wear barrier attached (1 piece) each |
A4383 | Urinary rubber pouch wo fp | Description: Ostomy pouch urinary for use on faceplate rubber each |
A4382 | Urinary hvy plstc pch wo fp | Description: Ostomy pouch urinary for use on faceplate heavy plastic each |
A4381 | Urinary plastic pouch wo fp | Description: Ostomy pouch urinary for use on faceplate plastic each |
A4380 | Urinary rubber pouch w fcplt | Description: Ostomy pouch urinary with faceplate attached rubber each |
A4387 | Ost clsd pouch w att st barr | Description: Ostomy pouch closed with barrier attached with built-in convexity (1 piece) each |
A4385 | Ost skn barrier sld ext wear | Description: Ostomy skin barrier solid 4 x 4 or equivalent extended wear without built-in convexity each |
A4384 | Ostomy facepltsilicone ring | Description: Ostomy faceplate equivalent silicone ring each |
J7667 | Metaproterenol comp con | Description: Metaproterenol sulfate inhalation solution compounded product concentrated form per 10 milligrams |
J7665 | Mannitol for inhaler | Description: Mannitol administered through an inhaler 5 mg |
J7660 | Isoproterenol comp unit | Description: Isoproterenol hcl inhalation solution compounded product administered through dme unit dose form per milligram |
J7668 | Metaproterenol non-comp con | Description: Metaproterenol sulfate inhalation solution fda-approved final product non-compounded administered through dme concentrated form per 10 milligrams |
J7669 | Metaproterenol non-comp unit | Description: Metaproterenol sulfate inhalation solution fda-approved final product non-compounded administered through dme unit dose form per 10 milligrams |
G0921 | Doc pt reas no assess | Description: Documentation of patient reason(s) for not being able to assess (e.g. patient refuses endoscopic andor radiologic assessment) |
G0920 | Type loc act doc | Description: Type anatomic location and activity all documented |
G0922 | Type loc act not doc | Description: No documentation of disease type anatomic location and activity reason not given |
J0129 | Abatacept injection | Description: Injection abatacept 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician not for use when drug is self administered) |
J0120 | Tetracyclin injection | Description: Injection tetracycline up to 250 mg |
G9658 | Toc tool incl elem not used | Description: A transfer of care protocol or handoff toolchecklist that includes the required key handoff elements is not used |
G9659 | >85y no hx colo carsn scope | Description: Patients greater than 85 years of age who did not have a history of colorectal cancer or valid medical reason for the colonoscopy including: iron deficiency anemia lower gastrointestinal bleeding crohns disease (i.e. regional enteritis) familial ade |
G9654 | Mon anesth care | Description: Monitored anesthesia care (mac) |
G9655 | Toc tool incl key elem | Description: A transfer of care protocol or handoff toolchecklist that includes the required key handoff elements is used |
G9656 | Pt trans from anest to pacu | Description: Patient transferred directly from anesthetizing location to pacu or other non-icu location |
G9657 | Toc dur aneth to icu | Description: Transfer of care during an anesthetic or to the intensive care unit |
G9650 | Doc pt no ther chg or contra | Description: Documentation that the patient declined therapy change or has documented contraindications (e.g. experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga bsa pasi or |
G9652 | Pt tx sys bio med psori 6mth | Description: Patient has been treated with a systemic or biologic medication for psoriasis for at least six months |
G9653 | Pt no tx sys bio rx 6 mths | Description: Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months |
LD | Left ant des coronary artery | Description: Left anterior descending coronary artery |
A0384 | Bls defibrillation supplies | Description: Bls specialized service disposable supplies defibrillation (used by als ambulances and bls ambulances in jurisdictions where defibrillation is permitted in bls ambulances) |
LC | Lft circum coronary artery | Description: Left circumflex coronary artery |
A0380 | Basic life support mileage | Description: Bls mileage (per mile) |
LL | Leaserental (appld to pur) | Description: Leaserental (use the ll modifier when dme equipment rental is to be applied against the purchase price) |
LM | Left main coronary artery | Description: Left main coronary artery |
L5200 | Kne sing axis fric shin sach | Description: Above knee molded socket single axis constant friction knee shin sach foot |
LT | Left side | Description: Left side (used to identify procedures performed on the left side of the body) |
LR | Laboratory round trip | Description: Laboratory round trip |
LS | Fda-monitored iol implant | Description: Fda-monitored intraocular lens implant |
A9155 | Artificial saliva | Description: Artificial saliva 30 ml |
A9150 | Miscexper non-prescript dru | Description: Non-prescription drugs |
A9153 | Multi-vitamin nos | Description: Multiple vitamins with or without minerals and trace elements oral per dose not otherwise specified |
A9152 | Single vitamin nos | Description: Single vitaminmineraltrace element oral per dose not otherwise specified |
L1 | Separately payable lab test | Description: Provider attestation that the hospital laboratory test(s) is not packaged under the hospital opps |
B4155 | Ef incompletemodular | Description: Enteral formula nutritionally incompletemodular nutrients includes specific nutrients carbohydrates (e.g. glucose polymers) proteinsamino acids (e.g. glutamine arginine) fat (e.g. medium chain triglycerides) or combination administered through |
B4154 | Ef spec metabolic noninherit | Description: Enteral formula nutritionally complete for special metabolic needs excludes inherited disease of metabolism includes altered composition of proteins fats carbohydrates vitamins andor minerals may include fiber administered through an enteral fee |
B4157 | Ef special metabolic inherit | Description: Enteral formula nutritionally complete for special metabolic needs for inherited disease of metabolism includes proteins fats carbohydrates vitamins and minerals may include fiber administered through an enteral feeding tube 100 calories = 1 unit |
B4150 | Ef complet wintact nutrient | Description: Enteral formula nutritionally complete with intact nutrients includes proteins fats carbohydrates vitamins and minerals may include fiber administered through an enteral feeding tube 100 calories = 1 unit |
B4153 | Ef hydrolyzedamino acids | Description: Enteral formula nutritionally complete hydrolyzed proteins (amino acids and peptide chain) includes fats carbohydrates vitamins and minerals may include fiber administered through an enteral feeding tube 100 calories = 1 unit |
B4152 | Ef calorie dense>=1.5kcal | Description: Enteral formula nutritionally complete calorically dense (equal to or greater than 1.5 kcalml) with intact nutrients includes proteins fats carbohydrates vitamins and minerals may include fiber administered through an enteral feeding tube 100 ca |
B4159 | Ef ped complete soy based | Description: Enteral formula for pediatrics nutritionally complete soy based with intact nutrients includes proteins fats carbohydrates vitamins and minerals may include fiber andor iron administered through an enteral feeding tube 100 calories = 1 unit |
B4158 | Ef ped complete intact nut | Description: Enteral formula for pediatrics nutritionally complete with intact nutrients includes proteins fats carbohydrates vitamins and minerals may include fiber andor iron administered through an enteral feeding tube 100 calories = 1 unit |
J2562 | Plerixafor injection | Description: Injection plerixafor 1 mg |
J2560 | Phenobarbital sodium inj | Description: Injection phenobarbital sodium up to 120 mg |
V5268 | Ald telephone amplifier | Description: Assistive listening device telephone amplifier any type |
V5269 | Alerting device any type | Description: Assistive listening device alerting any type |
L0180 | Cer post col occman sup adj | Description: Cervical multiple post collar occipitalmandibular supports adjustable |
V5265 | Ear moldinsert disp | Description: Ear moldinsert disposable any type |
V5266 | Battery for hearing device | Description: Battery for use in hearing device |
V5267 | Hearing aid supaccessdev | Description: Hearing aid or assistive listening devicesuppliesaccessories not otherwise specified |
V5260 | Hearing aid digit bin ite | Description: Hearing aid digital binaural ite |
V5261 | Hearing aid digit bin bte | Description: Hearing aid digital binaural bte |
V5262 | Hearing aid disp monaural | Description: Hearing aid disposable any type monaural |
V5263 | Hearing aid disp binaural | Description: Hearing aid disposable any type binaural |
S5170 | Homedelivered prepared meal | Description: Home delivered meals including preparation per meal |
L0980 | Peroneal straps pair pre ots | Description: Peroneal straps prefabricated off-the-shelf pair |
S5013 | 5%dextrose0.45%saline1000ml | Description: 5% dextrose0.45% normal saline with potassium chloride and magnesium sulfate 1000 ml |
L0982 | Stocking sup grips 4 pre ots | Description: Stocking supporter grips prefabricated off-the-shelf set of four (4) |
S5011 | 5% dextrose in lactated ring | Description: 5% dextrose in lactated ringers 1000 ml |
L0984 | Protect body sock ea pre ots | Description: Protective body sock prefabricated off-the-shelf each |
S5014 | D5w0.45ns w kcl and mgs04 | Description: 5% dextrose0.45% normal saline with potassium chloride and magnesium sulfate 1500 ml |
A4408 | Ext wear ost skn barr >4sq",37" | Description: Ostomy skin barrier with flange (solid flexible or accordion) extended wear with built-in convexity larger than 4 x 4 inches each |
A4409 | Ost skn barr convex <=4 sq i | Description: Ostomy skin barrier with flange (solid flexible or accordion) extended wear without built-in convexity 4 x 4 inches or smaller each |
A4404 | Ostomy ring each | Description: Ostomy ring each |
A4405 | Nonpectin based ostomy paste | Description: Ostomy skin barrier non-pectin based paste per ounce |
A4406 | Pectin based ostomy paste | Description: Ostomy skin barrier pectin-based paste per ounce |
A4407 | Ext wear ost skn barr <=4sq",37" | Description: Ostomy skin barrier with flange (solid flexible or accordion) extended wear with built-in convexity 4 x 4 inches or smaller each |
A4400 | Ostomy irrigation set | Description: Ostomy irrigation set |
A4402 | Lubricant per ounce | Description: Lubricant per ounce |
L5540 | Prep bk ptb laminated socket | Description: Preparatory below knee ptb type socket non-alignable system pylon no cover sach foot laminated socket molded to model |
L4361 | Pneumavac walk boot pre ots | Description: Walking boot pneumatic andor vacuum with or without joints with or without interface material prefabricated off-the-shelf |
H0009 | Alcohol andor drug services | Description: Alcohol andor drug services acute detoxification (hospital inpatient) |
H0008 | Alcohol andor drug services | Description: Alcohol andor drug services sub-acute detoxification (hospital inpatient) |
H0005 | Alcohol andor drug services | Description: Alcohol andor drug services group counseling by a clinician |
H0004 | Alcohol andor drug services | Description: Behavioral health counseling and therapy per 15 minutes |
H0007 | Alcohol andor drug services | Description: Alcohol andor drug services crisis intervention (outpatient) |
H0006 | Alcohol andor drug services | Description: Alcohol andor drug services case management |
H0001 | Alcohol andor drug assess | Description: Alcohol andor drug assessment |
H0003 | Alcohol andor drug screenin | Description: Alcohol andor drug screening laboratory analysis of specimens for presence of alcohol andor drugs |
H0002 | Alcohol andor drug screenin | Description: Behavioral health screening to determine eligibility for admission to treatment program |
G0248 | Demonstrate use home inr mon | Description: Demonstration prior to initiation of home inr monitoring for patient with either mechanical heart valve(s) chronic atrial fibrillation or venous thromboembolism who meets medicare coverage criteria under the direction of a physician includes: face-t |
G0249 | Provide inr test materequip | Description: Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s) chronic atrial fibrillation or venous thromboembolism who meets medicare coverage criteria includes: provision of materials for use in th |
G0245 | Initial foot exam pt lops | Description: Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops (2) a patient history (3) a physical examination that con |
G0246 | Followup eval of foot pt lop | Description: Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history (2) a physical examination that includes: (a) |
G0247 | Routine footcare pt w lops | Description: Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following |
S2095 | Transcath emboliz microspher | Description: Transcatheter occlusion or embolization for tumor destruction percutaneous any method using yttrium-90 microspheres |
L2600 | Hip clevisthrust bearing fr | Description: Addition to lower extremity pelvic control hip joint clevis type or thrust bearing free each |
L5050 | Ank symes mold sckt sach ft | Description: Ankle symes molded socket sach foot |
J2850 | Inj secretin synthetic human | Description: Injection secretin synthetic human 1 microgram |
L3510 | Orthopedic shoe add rub insl | Description: Orthopedic shoe addition insole rubber |
J0800 | Corticotropin injection | Description: Injection corticotropin up to 40 units |
S8121 | O2 contents liquid lb | Description: Oxygen contents liquid 1 unit equals 1 pound |
S8120 | O2 contents gas cubic ft | Description: Oxygen contents gaseous 1 unit equals 1 cubic foot |
A4246 | Betadinephisohex solution | Description: Betadine or phisohex solution per pint |
A4247 | Betadineiodine swabswipes | Description: Betadine or iodine swabswipes per box |
A4244 | Alcohol or peroxide per pint | Description: Alcohol or peroxide per pint |
A4245 | Alcohol wipes per box | Description: Alcohol wipes per box |
A4248 | Chlorhexidine antisept | Description: Chlorhexidine containing antiseptic 1 ml |
G9001 | Mccd initial rate | Description: Coordinated care fee initial rate |
G9003 | Mccd risk adj hi initial | Description: Coordinated care fee risk adjusted high initial |
G9002 | Mccdmaintenance rate | Description: Coordinated care fee maintenance rate |
G9005 | Mccd risk adj maintenance | Description: Coordinated care fee risk adjusted maintenance |
G9004 | Mccd risk adj lo initial | Description: Coordinated care fee risk adjusted low initial |
G9007 | Mccd sch team conf | Description: Coordinated care fee scheduled team conference |
G9006 | Mccd home monitoring | Description: Coordinated care fee home monitoring |
G9009 | Mccd risk adj level 3 | Description: Coordinated care fee risk adjusted maintenance level 3 |
G9008 | Mccdphys coor-care ovrsght | Description: Coordinated care fee physician coordinated care oversight services |
K0069 | Rr whl compl sol tire rep ea | Description: Rear wheel assembly complete with solid tire spokes or molded replacement only each |
S8431 | Compression bandage | Description: Compression bandage roll |
S2102 | Islet cell tissue transplant | Description: Islet cell tissue transplant from pancreas allogeneic |
K0065 | Spoke protectors | Description: Spoke protectors each |
G8717 | Less 1.2 ktv | Description: Spktv less than 1.2 (single-pool clearance of urea [kt] volume [v]) reason not given |
G8714 | Hemodialysis 3 times week | Description: Hemodialysis treatment performed exactly three times per week for > 90 days |
G8712 | Not pres antibiotic | Description: Antibiotic not prescribed or dispensed |
G8713 | Spktv great 1.2 ktv | Description: Spktv greater than or equal to 1.2 (single-pool clearance of urea [kt] volume [v]) |
G8710 | Pt pres antibiotic | Description: Patient prescribed or dispensed antibiotic |
G8718 | Great 1.7 ktv per week | Description: Total ktv greater than or equal to 1.7 per week (total clearance of urea [kt] volume [v]) |
G9391 | Achv refrac 1d | Description: Patient achieves refraction -1 d for the eye that underwent cataract surgery measured at the one month follow up visit |
E0273 | Bed board | Description: Bed board |
E0272 | Mattress foam rubber | Description: Mattress foam rubber |
E0271 | Mattress innerspring | Description: Mattress innerspring |
E0270 | Hospital bed institutional t | Description: Hospital bed institutional type includes: oscillating circulating and stryker frame with mattress |
E0277 | Powered pres-redu air mattrs | Description: Powered pressure-reducing air mattress |
E0276 | Bed pan fracture | Description: Bed pan fracture metal or plastic |
E0275 | Bed pan standard | Description: Bed pan standard metal or plastic |
E0274 | Over-bed table | Description: Over-bed table |
J9033 | Inj. treanda 1 mg | Description: Injection bendamustine hcl (treanda) 1 mg |
J9032 | Injection belinostat 10mg | Description: Injection belinostat 10 mg |
J9035 | Bevacizumab injection | Description: Injection bevacizumab 10 mg |
J9034 | Inj. bendeka 1 mg | Description: Injection bendamustine hcl (bendeka) 1 mg |
S9211 | Home mgmt gest hypertension | Description: Home management of gestational hypertension includes administrative services professional pharmacy services care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately) per diem (do not use this code with any |
J9039 | Injection blinatumomab | Description: Injection blinatumomab 1 microgram |
E1580 | Unipuncture control system | Description: Unipuncture control system for hemodialysis |
S9212 | Hm postpar hyper per diem | Description: Home management of postpartum hypertension includes administrative services professional pharmacy services care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately) per diem (do not use this code with any |
A4651 | Calibrated microcap tube | Description: Calibrated microcapillary tube each |
A4650 | Implant radiation dosimeter | Description: Implantable radiation dosimeter each |
A4653 | Pd catheter anchor belt | Description: Peritoneal dialysis catheter anchoring device belt each |
A4652 | Microcapillary tube sealant | Description: Microcapillary tube sealant |
A4657 | Syringe wwo needle | Description: Syringe with or without needle each |
L4090 | Repl met band kafo-afo calf | Description: Replace metal bands kafo-afo calf or distal thigh |
E0181 | Press pad alternating w pum | Description: Powered pressure reducing mattress overlaypad alternating with pump includes heavy duty |
E0182 | Replace pump alt press pad | Description: Pump for alternating pressure pad for replacement only |
E0185 | Gel pressure mattress pad | Description: Gel or gel-like pressure pad for mattress standard mattress length and width |
E0184 | Dry pressure mattress | Description: Dry pressure mattress |
E0187 | Water pressure mattress | Description: Water pressure mattress |
E0186 | Air pressure mattress | Description: Air pressure mattress |
E0189 | Lambswool sheepskin pad | Description: Lambswool sheepskin pad any size |
E0188 | Synthetic sheepskin pad | Description: Synthetic sheepskin pad |
J2950 | Promazine hcl injection | Description: Injection promazine hcl up to 25 mg |
J2778 | Ranibizumab injection | Description: Injection ranibizumab 0.1 mg |
J2770 | Quinupristindalfopristin | Description: Injection quinupristindalfopristin 500 mg (150350) |
V2399 | Lens trifocal speciality | Description: Specialty trifocal (by report) |
E0988 | Lever-activated wheel drive | Description: Manual wheelchair accessory lever-activated wheel drive pair |
E0981 | Seat upholstery replacement | Description: Wheelchair accessory seat upholstery replacement only each |
E0980 | Wheelchair safety vest | Description: Safety vest wheelchair |
E0983 | Add pwr joystick | Description: Manual wheelchair accessory power add-on to convert manual wheelchair to motorized wheelchair joystick control |
E0982 | Back upholstery replacement | Description: Wheelchair accessory back upholstery replacement only each |
J7306 | Levonorgestrel implant sys | Description: Levonorgestrel (contraceptive) implant system including implants and supplies |
E0984 | Add pwr tiller | Description: Manual wheelchair accessory power add-on to convert manual wheelchair to motorized wheelchair tiller control |
E0986 | Man wc push-rim powr system | Description: Manual wheelchair accessory push-rim activated power assist system |
E1050 | Whelchr fxd full length arms | Description: Fully-reclining wheelchair fixed full length arms swing away detachable elevating leg rests |
E2231 | Solid seat support base | Description: Manual wheelchair accessory solid seat support base (replaces sling seat) includes any type mounting hardware |
E2230 | Manual standing system | Description: Manual wheelchair accessory manual standing system |
S1034 | Art pancreas system | Description: Artificial pancreas device system (e.g. low glucose suspend (lgs) feature) including continuous glucose monitor blood glucose device insulin pump and computer algorithm that communicates with all of the devices |
S1035 | Art pancreas inv disp sensor | Description: Sensor invasive (e.g. subcutaneous) disposable for use with artificial pancreas device system |
S1036 | Art pancreas ext transmitter | Description: Transmitter external for use with artificial pancreas device system |
S1037 | Art pancreas ext receiver | Description: Receiver (monitor) external for use with artificial pancreas device system |
S1030 | Gluc monitor purchase | Description: Continuous noninvasive glucose monitoring device purchase (for physician interpretation of data use cpt code) |
S1031 | Gluc monitor rental | Description: Continuous noninvasive glucose monitoring device rental including sensor sensor replacement and download to monitor (for physician interpretation of data use cpt code) |
E1630 | Reciprocating peritoneal dia | Description: Reciprocating peritoneal dialysis system |
E1632 | Wearable artificial kidney | Description: Wearable artificial kidney each |
E1634 | Peritoneal dialysis clamp | Description: Peritoneal dialysis clamps each |
E1635 | Compact travel hemodialyzer | Description: Compact (portable) travel hemodialyzer system |
E1636 | Sorbent cartridges per 10 | Description: Sorbent cartridges for hemodialysis per 10 |
E1637 | Hemostats for dialysis each | Description: Hemostats each |
E1639 | Scale each | Description: Scale each |
L3070 | Arch suprt att to sho longit | Description: Foot arch support non-removable attached to shoe longitudinal each |
J8565 | Gefitinib oral | Description: Gefitinib oral 250 mg |
J8560 | Etoposide oral 50 mg | Description: Etoposide oral 50 mg |
J8562 | Oral fludarabine phosphate | Description: Fludarabine phosphate oral 10 mg |
L6935 | Below elbow myoelectronic ct | Description: Below elbow external power self-suspended inner socket removable forearm shell otto bock or equal electrodes cables two batteries and one charger myoelectronic control of terminal device |
L6930 | Below elbow switch control | Description: Below elbow external power self-suspended inner socket removable forearm shell otto bock or equal switch cables two batteries and one charger switch control of terminal device |
Q4131 | Epifix or epicord | Description: Epifix or epicord per square centimeter |
Q4132 | Grafix core grafixpl core | Description: Grafix core and grafixpl core per square centimeter |
L3219 | Orthopedic mens shoes oxford | Description: Orthopedic footwear mens shoe oxford each |
H1011 | Family assessment | Description: Family assessment by licensed behavioral health professional for state defined purposes |
H1010 | Nonmed family planning ed | Description: Non-medical family planning education per session |
L3211 | Surgical boot each junior | Description: Surgical boot each junior |
L3213 | Benesch boot pair child | Description: Benesch boot pair child |
L3212 | Benesch boot pair infant | Description: Benesch boot pair infant |
L3215 | Orthopedic ftwear ladies oxf | Description: Orthopedic footwear ladies shoe oxford each |
L3214 | Benesch boot pair junior | Description: Benesch boot pair junior |
L3217 | Ladies shoes hightop depth i | Description: Orthopedic footwear ladies shoe hightop depth inlay each |
L3216 | Orthoped ladies shoes dpth i | Description: Orthopedic footwear ladies shoe depth inlay each |
T4539 | Reuse diaperbrief any size | Description: Incontinence product diaperbrief reusable any size each |
J1459 | Inj ivig privigen 500 mg | Description: Injection immune globulin (privigen) intravenous non-lyophilized (e.g. liquid) 500 mg |
J1458 | Galsulfase injection | Description: Injection galsulfase 1 mg |
J1457 | Gallium nitrate injection | Description: Injection gallium nitrate 1 mg |
J1324 | Enfuvirtide injection | Description: Injection enfuvirtide 1 mg |
J1455 | Foscarnet sodium injection | Description: Injection foscarnet sodium per 1000 mg |
J1452 | Intraocular fomivirsen na | Description: Injection fomivirsen sodium intraocular 1.65 mg |
J1451 | Fomepizole 15 mg | Description: Injection fomepizole 15 mg |
J1322 | Elosulfase alfa injection | Description: Injection elosulfase alfa 1 mg |
G0010 | Admin hepatitis b vaccine | Description: Administration of hepatitis b vaccine |
A9 | Dressing for 9 or more wound | Description: Dressing for nine or more wounds |
V2715 | Prism lenses | Description: Prism per lens |
L5910 | Endo below knee alignable sy | Description: Addition endoskeletal system below knee alignable system |
L2038 | Kafo wo joint multi-axis an | Description: Knee ankle foot orthosis full plastic with or without free motion knee multi-axis ankle custom fabricated |
L2030 | Kafo dbl solid stirrup wo j | Description: Knee ankle foot orthosis double upright free ankle solid stirrup thigh and calf bandscuffs (double bar ak orthosis) without knee joint custom fabricated |
L2036 | Kafo plas doub free knee mol | Description: Knee ankle foot orthosis full plastic double upright with or without free motion knee with or without free motion ankle custom fabricated |
L2037 | Kafo plas sing free knee mol | Description: Knee ankle foot orthosis full plastic single upright with or without free motion knee with or without free motion ankle custom fabricated |
L2034 | Kafo pla sin up wwo ka cus | Description: Knee ankle foot orthosis full plastic single upright with or without free motion knee medial lateral rotation control with or without free motion ankle custom fabricated |
L2035 | Kafo plastic pediatric size | Description: Knee ankle foot orthosis full plastic static (pediatric size) without free motion ankle prefabricated includes fitting and adjustment |
L5930 | High activity knee frame | Description: Addition endoskeletal system high activity knee control frame |
V5299 | Hearing service | Description: Hearing service miscellaneous |
V5298 | Hearing aid noc | Description: Hearing aid not otherwise classified |
J0490 | Belimumab injection | Description: Injection belimumab 10 mg |
S9992 | Transportation costs to and | Description: Transportation costs to and from trial location and local transportation costs (e.g. fares for taxicab or bus) for clinical trial participant and one caregivercompanion |
S9991 | Services provided as part of | Description: Services provided as part of a phase iii clinical trial |
K0827 | Pwc gp vhd cap chair | Description: Power wheelchair group 2 very heavy duty captains chair patient weight capacity 451 to 600 pounds |
J7648 | Isoetharine non-comp con | Description: Isoetharine hcl inhalation solution fda-approved final product non-compounded administered through dme concentrated form per milligram |
J7649 | Isoetharine non-comp unit | Description: Isoetharine hcl inhalation solution fda-approved final product non-compounded administered through dme unit dose form per milligram |
S9994 | Lodging costs (e.g. hotel ch | Description: Lodging costs (e.g. hotel charges) for clinical trial participant and one caregivercompanion |
J7316 | Inj ocriplasmin 0.125 mg | Description: Injection ocriplasmin 0.125 mg |
J7645 | Ipratropium bromide comp | Description: Ipratropium bromide inhalation solution compounded product administered through dme unit dose form per milligram |
S9447 | Infant safety class | Description: Infant safety (including cpr) classes non-physician provider per session |
J3360 | Diazepam injection | Description: Injection diazepam up to 5 mg |
J7312 | Dexamethasone intra implant | Description: Injection dexamethasone intravitreal implant 0.1 mg |
J7310 | Ganciclovir long act implant | Description: Ganciclovir 4.5 mg long-acting implant |
G0909 | Hbg not doc | Description: Hemoglobin level measurement not documented reason not given |
G0908 | Hgb > 12 gdl | Description: Most recent hemoglobin (hgb) level > 12.0 gdl |
G9638 | >= 2 same hi-rsk med not ord | Description: At least two orders for the same high-risk medications not ordered |
G9632 | Med rsn for no rpt uret inj | Description: Documented medical reasons for not reporting ureter injury (e.g. gynecologic or other pelvic malignancy documented concurrent surgery involving bladder pathology injury that occurs during a urinary incontinence procedure patient death from non-medical |
G9637 | >= 2 same hi-rsk med ord | Description: At least two orders for the same high-risk medication |
C9349 | Puraply puraply antimic | Description: Puraply and puraply antimicrobial any type per square centimeter |
T4533 | Youth size briefdiaper | Description: Youth sized disposable incontinence product briefdiaper each |
B4172 | Parenteral sol amino acid 5. | Description: Parenteral nutrition solution amino acid 5.5% through 7% (500 ml = 1 unit) - home mix |
J3145 | Testosterone undecanoate 1mg | Description: Injection testosterone undecanoate 1 mg |
L6000 | Part hand thumb rem | Description: Partial hand thumb remaining |
B4176 | Parenteral sol amino acid 7- | Description: Parenteral nutrition solution amino acid 7% through 8.5% (500 ml = 1 unit) - home mix |
J3140 | Testosterone suspension inj | Description: Injection testosterone suspension up to 50 mg |
B4178 | Parenteral sol amino acid > | Description: Parenteral nutrition solution: amino acid greater than 8.5% (500 ml = 1 unit) - home mix |
J2540 | Penicillin g potassium inj | Description: Injection penicillin g potassium up to 600000 units |
J2543 | Piperacillintazobactam | Description: Injection piperacillin sodiumtazobactam sodium 1 gram0.125 grams (1.125 grams) |
J2545 | Pentamidine non-comp unit | Description: Pentamidine isethionate inhalation solution fda-approved final product non-compounded administered through dme unit dose form per 300 mg |
J2547 | Injection peramivir | Description: Injection peramivir 1 mg |
L1300 | Body jacket mold to patient | Description: Other scoliosis procedure body jacket molded to patient model |
L4130 | Replace pretibial shell | Description: Replace pretibial shell |
L2050 | Hkafo torsion cable hip pelv | Description: Hip knee ankle foot orthosis torsion control bilateral torsion cables hip joint pelvic bandbelt custom fabricated |
T4537 | Reusable underpad bed size | Description: Incontinence product protective underpad reusable bed size each |
T2007 | Non-emer transport wait time | Description: Transportation waiting time air ambulance and non-emergency vehicle one-half (12) hour increments |
C2619 | Pmkr dual non rate-resp | Description: Pacemaker dual chamber non rate-responsive (implantable) |
C2618 | Probeneedle cryo | Description: Probeneedle cryoablation |
C2613 | Lung bx plug wdel sys | Description: Lung biopsy plug with delivery system |
C2615 | Sealant pulmonary liquid | Description: Sealant pulmonary liquid |
C2614 | Probe perc lumb disc | Description: Probe percutaneous lumbar discectomy |
C2617 | Stent non-cor tem wo del | Description: Stent non-coronary temporary without delivery system |
C2616 | Brachytx non-stryttrium-90 | Description: Brachytherapy source non-stranded yttrium-90 per source |
A9281 | Reachinggrabbing device | Description: Reachinggrabbing device any type any length each |
A9280 | Alert device noc | Description: Alert or alarm device not otherwise classified |
A9283 | Foot press off load supp dev | Description: Foot pressure off loadingsupportive device any type each |
A9282 | Wig any type | Description: Wig any type each |
A9285 | Inversion eversion cor devic | Description: Inversioneversion correction device |
A9284 | Non-electronic spirometer | Description: Spirometer non-electronic includes all accessories |
A9286 | Any hygienic item device | Description: Hygienic item or device disposable or non-disposable any type each |
A4463 | Surgical dress holder reuse | Description: Surgical dressing holder reusable each |
A4461 | Surgicl dress hold non-reuse | Description: Surgical dressing holder non-reusable each |
A4466 | Elastic garmentcovering | Description: Garment belt sleeve or other covering elastic or similar stretchable material any type each |
A4467 | Belt strap sleev grmnt cover | Description: Belt strap sleeve garment or covering any type |
A4465 | Non-elastic extremity binder | Description: Non-elastic binder for extremity |
E0635 | Patient lift electric | Description: Patient lift electric with seat or sling |
J8999 | Oral prescription drug chemo | Description: Prescription drug oral chemotherapeutic nos |
H0029 | Alcohol andor drug preventi | Description: Alcohol andor drug prevention alternatives service (services for populations that exclude alcohol and other drug use e.g. alcohol free social events) |
H0028 | Alcohol andor drug preventi | Description: Alcohol andor drug prevention problem identification and referral service (e.g. student assistance and employee assistance programs) does not include assessment |
H0023 | Alcohol andor drug outreach | Description: Behavioral health outreach service (planned approach to reach a targeted population) |
H0022 | Alcohol andor drug interven | Description: Alcohol andor drug intervention service (planned facilitation) |
H0021 | Alcohol andor drug training | Description: Alcohol andor drug training service (for staff and personnel not employed by providers) |
H0020 | Alcohol andor drug services | Description: Alcohol andor drug services methadone administration andor service (provision of the drug by a licensed program) |
H0027 | Alcohol andor drug preventi | Description: Alcohol andor drug prevention environmental service (broad range of external activities geared toward modifying systems in order to mainstream prevention through policy and law) |
H0026 | Alcohol andor drug preventi | Description: Alcohol andor drug prevention process service community-based (delivery of services to develop skills of impactors) |
H0025 | Alcohol andor drug preventi | Description: Behavioral health prevention education service (delivery of services with target population to affect knowledge attitude andor behavior) |
H0024 | Alcohol andor drug preventi | Description: Behavioral health prevention information dissemination service (one-way direct or non-direct contact with service audiences to affect knowledge and attitude) |
AH | Clinical psychologist | Description: Clinical psychologist |
J0795 | Corticorelin ovine triflutal | Description: Injection corticorelin ovine triflutate 1 microgram |
J1840 | Kanamycin sulfate 500 mg inj | Description: Injection kanamycin sulfate up to 500 mg |
L2628 | Metal frame recipro hip & ca | Description: Addition to lower extremity pelvic control metal frame reciprocating hip joint and cables |
L2627 | Plastic mold recipro hip & c | Description: Addition to lower extremity pelvic control plastic molded to patient model reciprocating hip joint and cables |
L2624 | Hip adj flex ext abduct cont | Description: Addition to lower extremity pelvic control hip joint adjustable flexion extension abduction control each |
L2622 | Hip joint adjustable flexion | Description: Addition to lower extremity pelvic control hip joint adjustable flexion each |
C5274 | Low cost skin substitute app | Description: Application of low cost skin substitute graft to trunk arms legs total wound surface area greater than or equal to 100 sq cm each additional 100 sq cm wound surface area or part thereof or each additional 1% of body area of infants and children or |
L2620 | Pelvic control hip heavy dut | Description: Addition to lower extremity pelvic control hip joint heavy duty each |
L9900 | O&p supplyaccessoryservice | Description: Orthotic and prosthetic supply accessory andor service component of another hcpcs l" code" |
L3530 | Ortho shoe add half sole | Description: Orthopedic shoe addition sole half |
S8451 | Splint wrist or ankle | Description: Splint prefabricated wrist or ankle |
S8450 | Splint digit | Description: Splint prefabricated digit (specify digit by use of modifier) |
S8101 | Spacer with mask | Description: Holding chamber or spacer for use with an inhaler or nebulizer with mask |
S8100 | Spacer without mask | Description: Holding chamber or spacer for use with an inhaler or nebulizer without mask |
G8486 | Report prev care measures | Description: I intend to report the preventive care measures group |
G8487 | Report ckd measures | Description: I intend to report the chronic kidney disease (ckd) measures group |
G8484 | Flu immunize no admin | Description: Influenza immunization was not administered reason not given |
G8482 | Flu immunize orderadmin | Description: Influenza immunization administered or previously received |
G8483 | Flu imm no admin doc rea | Description: Influenza immunization was not administered for reasons documented by clinician (e.g. patient allergy or other medical reasons patient declined or other patient reasons vaccine not available or other system reasons) |
G8489 | Cad measures grp | Description: I intend to report the coronary artery disease (cad) measures group |
A4268 | Female condom | Description: Contraceptive supply condom female each |
A4269 | Spermicide | Description: Contraceptive supply spermicide (e.g. foam gel) each |
A4264 | Intratubal occlusion device | Description: Permanent implantable contraceptive intratubal occlusion device(s) and delivery system |
A4265 | Paraffin | Description: Paraffin per pound |
A4266 | Diaphragm | Description: Diaphragm for contraceptive use |
A4267 | Male condom | Description: Contraceptive supply condom male each |
A4261 | Cervical cap contraceptive | Description: Cervical cap for contraceptive use |
A4262 | Temporary tear duct plug | Description: Temporary absorbable lacrimal duct implant each |
A4263 | Permanent tear duct plug | Description: Permanent long term non-dissolvable lacrimal duct implant each |
C9489 | Injection nusinersen | Description: Injection nusinersen 0.1 mg |
C9488 | Conivaptan hcl | Description: Injection conivaptan hydrochloride 1 mg |
C9481 | Injection reslizumab | Description: Injection reslizumab 1 mg |
C9480 | Injection trabectedin | Description: Injection trabectedin 0.1 mg |
C9483 | Injection atezolizumab | Description: Injection atezolizumab 10 mg |
C9482 | Sotalol hydrochloride iv | Description: Injection sotalol hydrochloride 1 mg |
C9485 | Injection olaratumab | Description: Injection olaratumab 10 mg |
C9484 | Injection eteplirsen | Description: Injection eteplirsen 10 mg |
C9487 | Ustekinumab iv inj 1 mg | Description: Ustekinumab for intravenous injection 1 mg |
C9486 | Inj granisetron ext | Description: Injection granisetron extended release 0.1 mg |
G8738 | Lvef < 40% | Description: Left ventricular ejection fraction (lvef) < 40% or documentation of severely or moderately depressed left ventricular systolic function |
G8739 | Lvef >= 40% | Description: Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function |
G8734 | Doc neg elder mal no plan | Description: Elder maltreatment screen documented as negative no follow-up required |
G8735 | Eld mal scrn pos no plan | Description: Elder maltreatment screen documented as positive follow-up plan not documented reason not given |
G8736 | Ldl-c <100mgdl | Description: Most current ldl-c <100mgdl |
G8737 | Ldl-c >=100mgdl | Description: Most current ldl-c >=100mgdl |
G8730 | Pain doc pos and plan | Description: Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
G8731 | Pain neg no plan | Description: Pain assessment using a standardized tool is documented as negative no follow-up plan required |
G8732 | No doc of pain | Description: No documentation of pain assessment reason not given |
G8733 | Doc pos elder mal scrn plan | Description: Elder maltreatment screen documented as positive and a follow-up plan is documented |
E0210 | Electric heat pad standard | Description: Electric heat pad standard |
E0215 | Electric heat pad moist | Description: Electric heat pad moist |
E0217 | Water circ heat pad w pump | Description: Water circulating heat pad with pump |
G9289 | Doc type nsm lung ca | Description: Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation |
G9288 | Doc medrsn no hist type rpt | Description: Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g. a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons) |
Q0173 | Trimethobenzamide hcl 250mg | Description: Trimethobenzamide hydrochloride 250 mg oral fda approved prescription anti-emetic for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
G9283 | Hist type doc on report | Description: Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation |
G9282 | Doc medrsn no histo type | Description: Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g. biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reasons |
G9281 | Pne scrn done doc not ind | Description: Screening performed and documentation that vaccination not indicatedpatient refusal |
G9280 | Pne not given norsn | Description: Pneumococcal vaccination not administered prior to discharge reason not specified |
G9287 | No antibio w in 10d of sympt | Description: Antibiotic regimen not prescribed within 10 days after onset of symptoms |
G9286 | Antibio rx w in 10d of sympt | Description: Antibiotic regimen prescribed within 10 days after onset of symptoms |
G9285 | Site not small cell lung ca | Description: Specimen site other than anatomic location of lung or is not classified as non small cell lung cancer |
G9284 | No hist type doc on report | Description: Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation |
J9019 | Erwinaze injection | Description: Injection asparaginase (erwinaze) 1000 iu |
J9017 | Arsenic trioxide injection | Description: Injection arsenic trioxide 1 mg |
J9015 | Aldesleukin injection | Description: Injection aldesleukin per single use vial |
B4222 | Parenteral supply kit homemi | Description: Parenteral nutrition supply kit home mix per day |
M2 | Medicare secondary payer | Description: Medicare secondary payer (msp) |
A4674 | Chemantisept solution 8oz | Description: Chemicalsantiseptics solution used to cleansterilize dialysis equipment per 8 oz |
A4673 | Ext line w easy lock connect | Description: Extension line with easy lock connectors used with dialysis |
A4672 | Drainage ext line dialysis | Description: Drainage extension line sterile for dialysis each |
A4671 | Disposable cycler set | Description: Disposable cycler set used with cycler dialysis machine each |
A4670 | Automatic bp monitor dial | Description: Automatic blood pressure monitor |